(2E,4E,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16S)-6-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-(hydroxymethyl)-7,7,12-trimethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-N-(4,5-dimethyl-2-oxooxolan-3-yl)-2-methylhepta-2,4-dienamide

Details

Top
Internal ID ce7f0b95-2c14-4ef9-9ea5-25ac8bd00bd9
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins > Cucurbitacin glycosides
IUPAC Name (2E,4E,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16S)-6-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-(hydroxymethyl)-7,7,12-trimethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-N-(4,5-dimethyl-2-oxooxolan-3-yl)-2-methylhepta-2,4-dienamide
SMILES (Canonical) CC1C(OC(=O)C1NC(=O)C(=CC=CC(C)C2CCC3(C2(CCC45C3CCC6C4(C5)CCC(C6(C)C)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C)O)O)O)CO)C)C)C
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)O[C@H]5CC[C@]67C[C@]68CC[C@@]9([C@H](CC[C@]9([C@@H]8CC[C@H]7C5(C)C)C)[C@H](C)/C=C/C=C(\C)/C(=O)NC1C(C(OC1=O)C)C)CO)CO)O)O)O
InChI InChI=1S/C60H95NO23/c1-25(11-10-12-26(2)50(74)61-37-27(3)28(4)76-51(37)75)31-15-17-57(9)35-14-13-34-56(7,8)36(16-18-58(34)23-59(35,58)19-20-60(31,57)24-64)81-54-49(46(73)47(33(22-63)80-54)82-52-44(71)41(68)38(65)29(5)77-52)84-55-48(43(70)40(67)32(21-62)79-55)83-53-45(72)42(69)39(66)30(6)78-53/h10-12,25,27-49,52-55,62-73H,13-24H2,1-9H3,(H,61,74)/b11-10+,26-12+/t25-,27?,28?,29+,30+,31-,32-,33-,34+,35+,36+,37?,38+,39+,40-,41-,42-,43+,44-,45-,46+,47-,48-,49-,52+,53+,54+,55+,57+,58-,59+,60+/m1/s1
InChI Key CRBBJENJSGTFTN-RUOZHNSQSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C60H95NO23
Molecular Weight 1198.40 g/mol
Exact Mass 1197.62948828 g/mol
Topological Polar Surface Area (TPSA) 372.00 Ų
XlogP 1.50
Atomic LogP (AlogP) -0.68
H-Bond Acceptor 23
H-Bond Donor 13
Rotatable Bonds 16

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2E,4E,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16S)-6-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-(hydroxymethyl)-7,7,12-trimethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-N-(4,5-dimethyl-2-oxooxolan-3-yl)-2-methylhepta-2,4-dienamide

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.4775 47.75%
Caco-2 - 0.8649 86.49%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.6884 68.84%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7748 77.48%
OATP1B3 inhibitior + 0.9203 92.03%
MATE1 inhibitior - 0.9646 96.46%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior + 0.9541 95.41%
P-glycoprotein inhibitior + 0.7452 74.52%
P-glycoprotein substrate + 0.6768 67.68%
CYP3A4 substrate + 0.7422 74.22%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8822 88.22%
CYP3A4 inhibition - 0.9151 91.51%
CYP2C9 inhibition - 0.8140 81.40%
CYP2C19 inhibition - 0.8376 83.76%
CYP2D6 inhibition - 0.9341 93.41%
CYP1A2 inhibition - 0.8705 87.05%
CYP2C8 inhibition + 0.7404 74.04%
CYP inhibitory promiscuity - 0.7125 71.25%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.5370 53.70%
Eye corrosion - 0.9856 98.56%
Eye irritation - 0.8982 89.82%
Skin irritation - 0.7255 72.55%
Skin corrosion - 0.9236 92.36%
Ames mutagenesis - 0.7154 71.54%
Human Ether-a-go-go-Related Gene inhibition + 0.7871 78.71%
Micronuclear + 0.7100 71.00%
Hepatotoxicity - 0.6975 69.75%
skin sensitisation - 0.8464 84.64%
Respiratory toxicity + 0.6778 67.78%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity + 0.8750 87.50%
Nephrotoxicity - 0.5852 58.52%
Acute Oral Toxicity (c) III 0.6293 62.93%
Estrogen receptor binding + 0.7523 75.23%
Androgen receptor binding + 0.7532 75.32%
Thyroid receptor binding + 0.6229 62.29%
Glucocorticoid receptor binding + 0.7879 78.79%
Aromatase binding + 0.7032 70.32%
PPAR gamma + 0.8220 82.20%
Honey bee toxicity - 0.5954 59.54%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9580 95.80%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.23% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.25% 97.25%
CHEMBL218 P21554 Cannabinoid CB1 receptor 95.17% 96.61%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.13% 96.09%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 92.62% 92.88%
CHEMBL2581 P07339 Cathepsin D 92.08% 98.95%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 91.60% 96.77%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 91.51% 95.58%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 91.26% 96.21%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.51% 89.00%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 90.45% 98.75%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.04% 94.45%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 90.00% 96.38%
CHEMBL4005 P42336 PI3-kinase p110-alpha subunit 87.24% 97.47%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 87.01% 85.14%
CHEMBL3267 P48736 PI3-kinase p110-gamma subunit 86.90% 95.71%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.32% 97.14%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 85.82% 95.71%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.65% 99.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.62% 95.89%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.60% 97.09%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 84.34% 94.33%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 84.27% 91.24%
CHEMBL5255 O00206 Toll-like receptor 4 83.94% 92.50%
CHEMBL4227 P25090 Lipoxin A4 receptor 83.42% 100.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 82.70% 97.36%
CHEMBL2413 P32246 C-C chemokine receptor type 1 82.54% 89.50%
CHEMBL221 P23219 Cyclooxygenase-1 82.46% 90.17%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 81.95% 95.56%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 81.82% 100.00%
CHEMBL3359 P21462 Formyl peptide receptor 1 81.57% 93.56%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.06% 96.47%
CHEMBL340 P08684 Cytochrome P450 3A4 80.50% 91.19%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 80.26% 93.00%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 80.02% 95.83%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Mussaenda pubescens

Cross-Links

Top
PubChem 10677826
LOTUS LTS0060352
wikiData Q104968420